Protalix BioTherapeutics to Present at the Stifel 2026 Healthcare Conference
Protalix BioTherapeutics announced that CEO Dror Bashan will present a live corporate overview at the Stifel 2026 Healthcare Conference on November 10, 2026, in New York City. Management will also hold one-on-one meetings with registered investors, and a webcast plus archived replay will be available.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.